Microbix Biosystems Inc.
MBXBF
$0.19
$0.00-0.84%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -29.91% | -41.09% | -32.13% | -11.19% | -30.13% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -29.91% | -41.09% | -32.13% | -11.19% | -30.13% |
| Cost of Revenue | 8.91% | -22.45% | -11.98% | -23.90% | 1.90% |
| Gross Profit | -53.62% | -56.45% | -49.08% | 0.19% | -41.39% |
| SG&A Expenses | 2.80% | 6.54% | 3.49% | 15.57% | -36.31% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.48% | -8.28% | -3.70% | -6.56% | -17.31% |
| Operating Income | -188.50% | -290.29% | -1,128.91% | -63.44% | -59.27% |
| Income Before Tax | -236.75% | -357.50% | -758.51% | -94.86% | -66.08% |
| Income Tax Expenses | -- | -136.68% | -- | -- | -- |
| Earnings from Continuing Operations | -236.75% | -433.02% | -758.51% | -94.86% | -66.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -236.75% | -433.02% | -758.51% | -94.86% | -66.08% |
| EBIT | -188.50% | -290.29% | -1,128.91% | -63.44% | -59.27% |
| EBITDA | -139.37% | -225.63% | -257.82% | -33.98% | -50.23% |
| EPS Basic | -233.33% | -443.48% | -746.15% | -95.00% | -65.91% |
| Normalized Basic EPS | -235.71% | -304.00% | -1,866.67% | -92.31% | -66.27% |
| EPS Diluted | -239.53% | -452.17% | -769.23% | -95.00% | -67.42% |
| Normalized Diluted EPS | -235.71% | -304.00% | -1,866.67% | -92.31% | -66.27% |
| Average Basic Shares Outstanding | 3.07% | -2.92% | 2.73% | 1.80% | -1.10% |
| Average Diluted Shares Outstanding | 2.59% | -3.43% | 2.17% | 1.08% | -0.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |